AU611642B2 - Novel pharmacologically active phenoxazinones, processes for their preparation and their use - Google Patents

Novel pharmacologically active phenoxazinones, processes for their preparation and their use Download PDF

Info

Publication number
AU611642B2
AU611642B2 AU77441/87A AU7744187A AU611642B2 AU 611642 B2 AU611642 B2 AU 611642B2 AU 77441/87 A AU77441/87 A AU 77441/87A AU 7744187 A AU7744187 A AU 7744187A AU 611642 B2 AU611642 B2 AU 611642B2
Authority
AU
Australia
Prior art keywords
denotes
compound
hydrogen
preparation
dsm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU77441/87A
Other languages
English (en)
Other versions
AU7744187A (en
Inventor
Sabine Breiding-Mack
Susanne Grabley
Gerhard Seibert
Hartmut Voelskow
Axel Zeeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU7744187A publication Critical patent/AU7744187A/en
Application granted granted Critical
Publication of AU611642B2 publication Critical patent/AU611642B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/38—[b, e]-condensed with two six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU77441/87A 1986-08-27 1987-08-26 Novel pharmacologically active phenoxazinones, processes for their preparation and their use Ceased AU611642B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3629062 1986-08-27
DE3629062 1986-08-27

Publications (2)

Publication Number Publication Date
AU7744187A AU7744187A (en) 1988-03-31
AU611642B2 true AU611642B2 (en) 1991-06-20

Family

ID=6308253

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77441/87A Ceased AU611642B2 (en) 1986-08-27 1987-08-26 Novel pharmacologically active phenoxazinones, processes for their preparation and their use

Country Status (14)

Country Link
US (1) US4861775A (OSRAM)
EP (1) EP0260486B1 (OSRAM)
JP (1) JPS6371190A (OSRAM)
KR (1) KR880002844A (OSRAM)
AT (1) ATE60326T1 (OSRAM)
AU (1) AU611642B2 (OSRAM)
DE (1) DE3767621D1 (OSRAM)
DK (1) DK446087A (OSRAM)
ES (1) ES2031860T3 (OSRAM)
GR (1) GR3001560T3 (OSRAM)
HU (1) HU201354B (OSRAM)
IL (1) IL83646A0 (OSRAM)
IN (1) IN164557B (OSRAM)
ZA (1) ZA876353B (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03161441A (ja) * 1989-11-20 1991-07-11 Senjiyu Seiyaku Kk メイラード反応阻害剤
JPWO2006087935A1 (ja) * 2005-02-17 2008-07-03 独立行政法人科学技術振興機構 フェノキサジニウム化合物を活性成分として含有する医薬組成物
CN118955425B (zh) * 2024-07-31 2026-01-16 首都医科大学附属北京胸科医院 一种酚噁嗪类化合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4667032A (en) * 1983-01-21 1987-05-19 Merck Frosst Canada, Inc. Phenothiazone derivatives and analogs

Also Published As

Publication number Publication date
HU201354B (en) 1990-10-28
HUT44624A (en) 1988-03-28
US4861775A (en) 1989-08-29
IN164557B (OSRAM) 1989-04-08
AU7744187A (en) 1988-03-31
EP0260486A1 (de) 1988-03-23
IL83646A0 (en) 1988-01-31
ZA876353B (en) 1988-03-01
ATE60326T1 (de) 1991-02-15
DK446087D0 (da) 1987-08-26
JPS6371190A (ja) 1988-03-31
DE3767621D1 (de) 1991-02-28
DK446087A (da) 1988-02-28
ES2031860T3 (es) 1993-01-01
KR880002844A (ko) 1988-05-11
EP0260486B1 (de) 1991-01-23
GR3001560T3 (en) 1992-11-23

Similar Documents

Publication Publication Date Title
DE68909139T2 (de) Substanz FR901228 und deren Herstellung.
EP0271581A1 (en) Novel compounds dc-88a and dc-89a1 and process for their preparation
JPH0216756B2 (OSRAM)
US5089521A (en) 10-membered ring lactones, a process for the preparation thereof, and the use thereof
EP0001709A2 (en) Deoxynarasin antibiotics, their production and use
US4861775A (en) Pharmacological use of phenoxazinones
JP2833181B2 (ja) Ｆｒ９０１３７５物質およびその製造法
EP1296989B1 (en) Polycyclic xanthones as antibiotics
EP1090136B1 (en) Mumbaistatin, a process for its production and its use as a pharmaceutical
CA1146885A (en) Antibiotically active compounds and their fermentative preparation
US5100921A (en) Angucyclinones from streptomycetes, a process for the preparation thereof, and the use thereof
CA1306213C (en) Phenanthridine derivatives, process for the preparation thereof, and compositions containing them
EP0512522B1 (en) Novel antibiotic compounds and their production
US5137813A (en) Process for production of an antibiotic compound using zalerion arboricola
JPH05331171A (ja) プソイロチンｆ１／ｆ２、アスペルギルス・フミガタスから得られる新規な代謝産物、その調製方法およびその使用
JP4095116B2 (ja) スクレロデルマ・テキセンスからの抗真菌性ペプチド
US5994307A (en) Methods of treatment with novel antibiotic feglymycin
EP0436935A1 (en) A novel antibiotic Alisamycin a process for its production and its use
JP4750993B2 (ja) アミコマイシン、その製造方法および医薬品としてのその使用
CA2004304A1 (en) Angucyclinones from streptomycetes, a process for the preparation thereof and the use thereof
EP0818539A1 (en) Methylsulfomycin I, a process for its production and its use
US20020028921A1 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
US3986928A (en) Antibiotic a-32390 and process for preparation thereof
JPH0525150A (ja) 新規デカレストリクチン類および関連化合物、それらの製造方法およびそれらの使用
HK1038594A (en) Mumbaistatin, a process for its production and its use as a pharmaceutical